Przedsiębiorstwo Produkcyjno-Handlowe „EWA” S.A.
+ business areaCMO/CDMO/Biosimilars
+ annual revenue
2020 - 35,800,000 PLN
2021 - 33,100,000 PLN
2022 - 52,900,000 PLN
2023 - 70,900,000 PLN
2024 - 50,700,000 PLN
+ workforce (estimated if not reported)
2024 - 205
+ depreciation & amortization
2020 - 2,600,000 PLN
2021 - 2,900,000 PLN
2022 - 2,200,000 PLN
2023 - 2,000,000 PLN
2024 - 1,900,000 PLN
Polish contract manufacturer (CDMO) specializing in the production of OTC medicines, dietary supplements, and medical devices (class IIa). Provides full project support including formulation design, documentation, R&D, and quality control. Certified GMP, GDP, ISO 22000, ISO 13485. Operates one of the most advanced caramel-based production lines in Europe.